Phase I study of pemetrexed with sorafenib in advanced solid tumors

PURPOSE: To determine if combination treatment with pemetrexed and sorafenib is safe and tolerable in patients with advanced solid tumors. RESULTS: Thirty-seven patients were enrolled and 36 patients were treated (24 in cohort A; 12 in cohort B). The cohort A dose schedule resulted in problematic cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Poklepovic, Andrew, Gordon, Sarah, Shafer, Danielle A., Roberts, John D., Bose, Prithviraj, Geyer, Charles E., McGuire, William P., Tombes, Mary Beth, Shrader, Ellen, Strickler, Katie, Quigley, Maria, Wan, Wen, Kmieciak, Maciej, Massey, H. Davis, Booth, Laurence, Moran, Richard G., Dent, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173162/
https://www.ncbi.nlm.nih.gov/pubmed/27213589
http://dx.doi.org/10.18632/oncotarget.9434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173162/
https://www.ncbi.nlm.nih.gov/pubmed/27213589
http://dx.doi.org/10.18632/oncotarget.9434

Ejemplares similares